BioSpace News Archive

Business

Accuray Reports Fiscal 2024 Second Quarter Financial Results

Accuray Incorporated reported financial results for the second quarter and six-months ended December 31, 2023.

January 31, 2024
·
17 min read
Crystal Pharmatech’s CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit

Recently, Crystal Formulations Services, the CDMO Business Unit of Crystal Pharmatech has achieved a significant milestone by successfully passing the on-site audit conducted by the European Qualified Person, evaluating its GMP quality system and production facilities.

January 31, 2024
·
2 min read
FDA

W. L. Gore & Associates, Inc. Receives U.S. Food & Drug Administration (FDA) Approval for Lower Profile Gore® Viabahn® VBX Balloon Expandable Endoprosthesis, Now 6 FR Sheath Compatible

As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. announced recent FDA approval of a lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis.

January 31, 2024
·
4 min read
BioForest

Autoimmune Disease and Pregnancy: ISB Study Challenges Prevailing Wisdom, Unveils Nuances

An Institute for Systems Biology -led study showed nuanced pregnancy outcomes for pregnant individuals with autoimmune disease.

January 31, 2024
·
4 min read
Biotech Bay

Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium

Pulse Biosciences, Inc. (Nasdaq: PLSE) today announced that its nsPFA technology will be featured in a podium presentation at the 29th Annual AF Symposium in Boston, Massachusetts, on February 2, 2024 at 10:00am ET.

January 31, 2024
·
4 min read
Biotech Beach

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Conduit Pharmaceuticals Inc. today announced CEO Dr. David Tapolczay, will be participating in the Oppenheimer 34th Annual Healthcare Life Sciences Conference, being held February 13-14, 2024.

January 31, 2024
·
3 min read
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel SprayKane will introduce its unique spray gel at the Boswick Burn and Wound Care Symposium

Kane Biotech Inc. announces that it has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel, and will be introducing it today at the Boswick Burn and Wound Care Symposium.

January 31, 2024
·
3 min read
Ludwig Enterprises mRNA Bladder Cancer Study to be Launched

Ludwig Enterprises, Inc, (OTC PINK:LUDG): A US-based biotechnology company is pleased to announce that the company has received Continuing Review Approval on its planned clinical study from Advarra IRB, Columbia, MD.

January 31, 2024
·
2 min read
Stemtech Corporation Expands Global Reach with New License Agreement in Africa

Stemtech Corporation announces a significant milestone in its global expansion strategy with the signing of a license Agreement with an established direct sales company, based in Kenya.

January 31, 2024
·
5 min read
Pharm Country

The Cigna Group to Host Investor Day in New York City on March 7

Global health company The Cigna Group (NYSE:CI) will be hosting its Investor Day on Thursday, March 7, 2024 in New York City.

January 31, 2024
·
1 min read